Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Solithera (solithromycin) for the Treatment of Community-Acquired Bacterial Pneumonia

Drug (Brand/Generic)

Solithera (solithromycin)

Therapy Class

Fluoroketolide

Current Indication

Community-acquired bacterial pneumonia

Market Sector

Respiratory

Development Status

Under review in the US and Europe

Developer

Cempra
Expand

Go Top